Valuation: Tellgen Corporation

Market Cap 2.01B 296M 259M 239M 220M 418M 28.22B 425M 2.85B 1.12B 13.9B 1.11B 1.09B 47.79B P/E 2024
66.3x
P/E 2025 836x
Enterprise Value 1.8B 265M 232M 214M 197M 375M 25.26B 381M 2.55B 1B 12.44B 995M 973M 42.78B EV / Sales 2024
4.21x
EV / Sales 2025 7.5x
Free-Float
66.27%
Yield 2024
1.06%
Yield 2025 0.54%
1 day+4.15%
1 week-3.09%
Current month+6.36%
1 month-2.18%
3 months-26.09%
6 months-38.33%
Current year-31.76%
1 week 11.73
Extreme 11.73
13.08
1 month 11.4
Extreme 11.4
13.3
Current year 11.4
Extreme 11.4
22.87
1 year 11.4
Extreme 11.4
32.8
3 years 9.94
Extreme 9.94
32.8
5 years 9.94
Extreme 9.94
44.88
10 years 9.94
Extreme 9.94
50.25
Manager TitleAgeSince
Chief Executive Officer 56 06/11/2003
Director of Finance/CFO 50 09/06/2023
Chief Tech/Sci/R&D Officer 45 09/12/2020
Director TitleAgeSince
Chairman 56 06/11/2003
Director/Board Member 44 09/12/2020
Director/Board Member 47 09/12/2020
Change 5-day change 1-year change 3-year change Capi.($)
+4.15%-3.09%-17.05%-37.31% 296M
-2.46%-4.72%+212.05%+318.32% 21.22B
-2.58%+0.14%-42.60%-22.89% 9.41B
-0.33%-3.87%+26.02%+24.49% 6.88B
-0.86%+9.54%+238.59%-26.38% 5.42B
-4.92%-7.16%-36.18% - 4.8B
+3.74%-1.63%-21.48%-28.55% 5.05B
-1.04%-1.40%-24.44%-24.84% 4.17B
+0.75%-11.50%+60.79%+69.60% 3.64B
+0.62%-0.77%-18.44%-39.92% 2.59B
Average -0.29%-1.12%+37.73%+25.84% 6.35B
Weighted average by Cap. -1.37%-1.75%+84.37%+110.02%

Financials

2024 2025
Net sales 437M 64.42M 56.35M 51.97M 48M 91.08M 6.14B 92.61M 621M 244M 3.03B 242M 237M 10.4B 364M 53.66M 46.94M 43.29M 39.98M 75.87M 5.12B 77.15M 517M 203M 2.52B 201M 197M 8.67B
Net income 34.53M 5.09M 4.46M 4.11M 3.8M 7.2M 486M 7.32M 49.1M 19.28M 239M 19.12M 18.71M 823M 3.59M 529K 463K 427K 394K 748K 50.47M 761K 5.1M 2M 24.86M 1.99M 1.94M 85.47M
Net Debt -434M -64.04M -56.02M -51.67M -47.72M -90.55M -6.11B -92.08M -617M -242M -3.01B -240M -235M -10.34B -210M -31.02M -27.14M -25.03M -23.12M -43.86M -2.96B -44.6M -299M -117M -1.46B -116M -114M -5.01B
Logo Tellgen Corporation
Tellgen Corp is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic products. The Company's products mainly cover the fields of immunity, molecules and biochemistry, involving autoimmunity, tumors, cardiovascular, infection, hormones, metabolism and other fields. The Company's main products include tumor marker detection products, human papillomavirus (HPV) nucleic acid detection products, autoimmune disease detection products, methylation mutation detection products and other products. The Company conducts its business in the domestic and overseas markets.
Employees
683
Date Price Change Volume
10/07/26 CN¥12.55 +4.15% 4,892,238
09/07/26 CN¥12.05 -0.25% 2,833,760
08/07/26 CN¥12.08 -0.98% 2,386,300
07/07/26 CN¥12.20 -4.61% 3,335,900
06/07/26 CN¥12.79 -1.24% 3,837,612

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300642 Stock